SCHEMBL5548451

SCHEMBL5548451

Cc1oc(=O)oc1COC(=O)c1cccc2nc(C3CC3)n(Cc3ccc(-c4ccccc4)c(-c4noc(=O)[nH]4)c3)c12

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 2/20 0.67
PPARG P37231 3/20 0.41
AGTR1 P30556 4/20 0.41
ABCC3 O15438 1/20 0.38
ABCC4 O15439 1/20 0.38
ABCB11 O95342 1/20 0.38
CYP3A4 P08684 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3A Q14432 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683371 0.93 AGTR2 (0.78) AGTR2PPARGAGTR1
SCHEMBL2927273 0.92 AGTR2 (0.77) AGTR2PPARGAGTR1
Potassium SCHEMBL3033376 0.92 AGTR2 (0.77) AGTR2PPARGAGTR1
SCHEMBL15456840 0.88 AGTR2 (0.87) AGTR2PPARGAGTR1ABCC3ABCC4
Potassium SCHEMBL3757615 0.87 AGTR2 (0.86) AGTR2PPARGAGTR1ABCC3ABCC4
SCHEMBL3757603 0.87 AGTR2 (0.86) AGTR2PPARGAGTR1ABCC3ABCC4
SCHEMBL1380674 0.85 PPARG (0.46) AGTR2PPARGAGTR1
SCHEMBL15702902 0.84 AGTR2 (0.83) AGTR2PPARGAGTR1ABCC3ABCC4
SCHEMBL2132264 0.83 AGTR2 (0.63) AGTR2AGTR1ABCC3ABCC4ABCB11
SCHEMBL683639 0.82 AGTR2 (0.65) AGTR2PPARGAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863801-A2 BENZIMIDAZOLE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-12-12 EP disclosed
WO-2006107062-A2 BENZIMIDAZOLE DERIVATIVE AND USE AS ANGIOTENSIN II ANTAGONIST TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-12 WO disclosed